子行业二季度表现分化，电商行业变现最优：我们看到二季度行业平均估值仍低于历史平均。来自宏观消费放缓、广告主预算收紧、对贸易战的担心、短期的监管举措等种种不利因素叠加，印证了我们预期的二季度逆风的持续。从公司表现来看，电商行业二季度在收入和盈利端都带来惊喜，在高线和低线城市市场的渗透均取得进展，尤其在618 期间，平台持续的拉新成效显现，新用户随着时间推移逐渐提升在电商平台的消费支出，6 月电商渗透率达到23%的历史新高。

科技是历史的杠杆，是大国竞争的制高点。二战后，美国取代德国成为世界科技中心并保持至今，晶体管、计算机、互联网、手机、GPS、激光等20 世纪最重要的发明都出自美国。苏联、日本等曾一度冲击美国的高科技垄断地位，但均遭到美国的打击并最终告败。

The advent of new technologies, with stringent environment norms, increasing health safety measures have changed the entire industry viewpoint, with respect to the compliance of standards and regulations. Testing, inspection, and certification (TIC) plays a significant role to ensure the infrastructure, services, products are met with the standards and regulations pertaining to safety and quality. With inspection and testing at regular intervals across a few industries, such as oil and gas becoming mandatory, the TIC services are expected to grow in demand, irrespective of the industrial seasonality.

The synthetic biology market was valued at USD 22.47 billion, in 2018. The market is expected to register a growth rate of 34.91% over the forecast period. The primary drivers for the market include increasing support from government and private institutions and increasing R&D investments in drug discovery and development. Based on the product, the market was dominated by the enabled product in 2018. The fastest growing subsegment over the forecast period, under the product segmentation, was estimated to be enabled products. The enabled product sub-segment is expected to register a CAGR of 35.19% over the forecast period.

The adoption of single-use technology has proven to be a robust, scalable, and reliable form of sources from lab-scale to cGMP production applications, such as flexible contaminant, single-use bioprocessing equipment, and single-use filtration assemblies. Hence, the use of single-use technologies in virus filtration helps to marginally reduce the risk of cross-contamination, increasing the safety profile of the manufacturing process.

Currently, the healthcare industry in Nigeria is hindered by the lack of funds from the Nigerian government, often resulting in insufficient supply of medical equipment, administrative bottlenecks, and limited licensed medical laboratory professionals. The public healthcare expenditures are really less accounting for only about 5%, and private (out of pocket) expenditure to about 75%. This statistic is drastically different from several developed and emerging markets.

The integration of robotics and automation in labs is rapidly increasing, owing to the enhanced productivity and mitigated operational cost for laboratories. This is likely to boost the market growth during the forecast period. The progress in research and discovery of the organs, including the polymerase chain reaction (PCR), splice genes, means of sequencing, are on a rise, which may propel the market growth.